Stem cell transplantation therapy in animal heart models (Orlic et al. 2001; Kudo et al. 2003; Balsam et al. 2004) and patients with myocardial infarction (MI) (Strauer et al. 2002; Britten et al. 2003; Chen et al. 2004) has improved the cardiac function. However, the poor survival of the implanted cells in the host myocardium hampered the therapeutic efficacy (Reinecke et al. 1999; Toma et al. 2002) . It is necessary to improve the survival rate of the donor cells in the arduous microenvironment.
Ischemic preconditioning has been shown to improve tolerance in various body tissues including the heart (Yellon and Downey 2003; Wang et al. 2005) . Mitochondrial ATPsensitive potassium (Mito-KATP) channels have been shown to be a key factor for the ischemic preconditioning in the heart (Gross and Fryer 1999; Grover and Garlid 2000) . There is evidence linking the opening of mito-KATP channels to protect against myocardial infarction and apoptosis (Mironova et al. 1999 ). This effect has been mimicked via pharmacological intervention using a mito-KATP channel opener, diazoxide (Debska et al. 2002; Kicinska and Szewczyk 2003; O'Rourke 2004) . Diazoxide has been applied to suppress cell apoptosis and promote cell survival as the prototype mito-KATP channel opener (Kis et al. 2003) or others (Holmuhamedov et al. 2004; Dröse et al. 2006; Szewczyk et al. 2006) . Niagara et al. (2007) demonstrated that "preconditioning" rat skeletal myoblasts with diazoxide had improved the survival rate of the cells under oxidative stress and in the recipient myocardium.
Marrow mesenchymal stem cells (MMSC) have become one of the important therapeutic cells for myocardial infarction, due to the multi-differentiation potential and a unique low-immunogenicity. Experimental and clinical studies have confirmed the safety and efficacy of MMSCs applied to the heart (Heng et al. 2004; Wojakowski and Tendera 2005; Pallante et al. 2007 ). However, the problem that has been faced is the low efficiency of differentiation towards myocardial cells of MMSCs after transplantation. To overcome this difficulty, we selected a highly purified population of cells from MMSCs using a stem cell surface marker c-kit, as well as early cardiac transcription factors Nkx2.5, these cells have potential to differentiate specially towards cardiomyocytes. We named these cells as selected mesenchymal stem cells (SMSCs). Through early study, we found that SMSCs is more likely to differentiate into myocardial cells than mesenchymal stem cells (MSCs) in the heart of myocardial infarction (Zhang et al. 2007) .
To overcome the problem of extensive cell death and poor differentiation rate after cell transplantation, in our investigation, we preconditioned SMSCs with diazoxide to improve the therapeutic effect of MSCs transplantation after MI.
Materials and Methods

Experimental design in vitro
MSCs were isolated from the bone marrow of adult male SD rats. SMSCs were selected from MSCs with single-cell cloning culture by c-kit immunoflourence staining and RT-PCR analysis for Nkx2.5 using the method previously described (Zhang et al. 2007 ). The SMSCs were seeded in flasks at a density of 3.5 × 10 4 cells/cm 2 . One day after incubation, the cells were randomly divided into the control group, H 2 O 2 group, diazoxide (DZ) group and DZ + 5-hydroxydecanoic acid (5-HD) group. In H 2 O 2 group, 100 µ mol/L H 2 O 2 was added into the medium, the cells were incubated for two hours. In DZ group, the cells were pretreated with 200 µ mol/L diazoxide (Sigma Chemical Co., Saint Louis, USA) for thirty min and then treated with 100 µ mol/L H 2 O 2 for two hours. In DZ + 5-HD group, the cells were pretreated with 200 µ mol/L DZ and 200 µ mol/L 5-HD for thirty min and then treated with 100 µ mol/L H 2 O 2 for two hours. All experiments were performed in serum-and glucose-free DMEM.
Detection of lactate dehydrogenase leakage
Intracellular lactate dehydrogenase (LDH) leakage, a wellknown indicator of cell membrane integrity and viability, was measured using the cell-conditioned medium at two hours after incubation by a LDH Assay kit (Sigma Chemical Co., Saint Louis, USA) according to the instructions of the manufacturer.
Annexin V/Propidium Iodide (PI) staining
For Annexin V/Propidium Iodide (PI) staining, the cells were harvested and labeled with annexin V/PI using the Annexin V/PI apoptosis detection kit (Sigma Chemical Co., Saint Louis, USA) for flow cytometry. After being PI and annexin V stained, the apoptotic cells were only stained with annexin V, necrotic cells displayed both PI and annexin V staining, whereas live cells remained unstained.
Immunostaining for cytochrome C
Immunostaining for cytochrome c revealed that mitochondrial localization of cytochrome c is punctate appearance in normal cells. Cytochrome C in mitochondria translocated into cytoplasm and presented homogeneous distribution in the cytoplasm of the apoptotic cells. The cells were fixed with 4% paraformaldehyde for 10 min at room temperature and then incubated with mouse anti-cytochrome C primary antibody (Sigma Chemical Co., Saint Louis, USA) and goat anti-mouse secondary antibody (Sigma Chemical Co., Saint Louis, USA) conjugated with FITC, then the cells were observed by Olympus BX41 microscope equipped with digital camera for punctate (live cells) or diffused (early apoptotic cells) fluorescence in the cytoplasm.
Western blotting
To detecte the expression level of Akt and phosphor-Akt, the cells were treated with cell lysis buffer. The protein concentration of the samples was determined by BCA protein kit. 20 µ g total proteins were separated by 12.5% SDS-PAGE and then transferred to a 0.2 mm nitrocellulose membrane. The membrane was blocked in PBS buffer containing 0.2% Tween-20 and 5% skim milk overnight at 4°C. Subsequently, the blot was incubated with rabbit anti-rat Akt protein monoclonal antibody and mouse anti-rat phosphor-Akt protein monoclonal antibody (Sigma Chemical Co., Saint Louis, USA) for two hours. Antibody binding was detected with horseradish peroxidase (HRP) conjugated anti-rabbit and anti-mouse secondary antibody (Sigma Chemical Co., Saint Louis, USA), and visualized by ECL kit (Boster Biological Technology Co. Ltd., Wuhan, China).
Reverse-Transcription Polymerase Chain Reaction (RT-PCR)
To evaluate expression of hepatocyte growth factor (HGF), basic fibroblast growth factor (bFGF) and vascular endothelial growth factor (VEGF) in the cells, total RNA of the cells was isolated using an RNeasy mini kit (Sigma Chemical Co., Saint Louis, USA), their subsequent first-strand cDNA synthesis was performed by an Omniscript Reverse Transcription kit (Sigma Chemical Co., Saint Louis, USA). The following primer sequences were used for PCR:
GAPDH, forward 5´-CAGCCTCAAGATCATCAGCA-3´ reverse 5´-TGTGGTCATGAGTCCTTCCA-3´.
HGF, forward 5´-ATTTGGCCATGAATTTGACCT-3´ reverse 5´-ACTCCAGGGCTGACATTTGAT-3´.
bFGF, forward 5´-AAGCGGCTCTACTGCAAG-3´ reverse 5´-AGCCAGACATTGGAAGAAACA-3´; VEGF, forward 5´-AGAAGGAGGAGGGCAGAATC-3´ reverse 5´-ACACAGGATGGCTTGAAGATG-3´.
Establishment of the MI model and cell transplantation
Adult female S.D. rats (200 to 250 g, n = 30) were used in this experiment. The present study conforms to the Guide for the Care and Use of Laboratory Animals published by the US National Institutes of Health (NIH Publication No. 85-23, revised 1985) . the protocol was approved by the Institutional Animal Care and Use Committee of Fudan University. The animals were anesthetized by intraperitoneal injection of ketamine (24 mg/kg body weight). After endotracheal intubation and ventilation using Apparatus Rodent Ventilator (model no. 683), the heart was exposed via minimal leftsided thoracotomy. The left anterior descending of coronary artery was ligated with Prolene 6.0 suture. Whether the MI model is successful or not was determined by observing a pale discoloration region below the ligation areas and an ST elevation on electrocardiograms. Thirty min later, the animals were divided into control, SMSCs and DZ-pretreated SMSCs groups. In the control and SMSCs groups, 80 µ L PBS and SMSCs (1.0 × 10 6 cells in PBS) were injected at four sites on the border of the infarct zone respectively. In DZpretreated SMSCs group, the cells were pretreated with DZ (200 µ mol/L) for thirty min. The chests of animals were sutured, and then animals were allowed to recover.
Masson staining
To examine infarct size, frozen sections were prepared and stained with Masson trichrome. From every heart, intermittent nine slices of the infarcted region were used for the measurement of scar size. The ratio of scar length and entire circumference defined the infarct extent for the endocardial and epicardial surfaces respectively. The final infarct size was determined as the average of endocardial and epicardial surfaces and was given in percent. Quantitative assessment of collagen deposition (green) was performed with a multi-purpose color image processor. An investigator blinded to perform the analysis.
Fluorescence in situ hybridization (FISH)
The frozen sections were fixed with methanol and acetic acid (3 : 1) at 4°C for thirty minutes, to denature fixed chromosome specimens by immersing the slides in denaturated buffer (70% formamide, 2 × SSC) at 95°C for five minutes. Dehydrating slides through gradient ethanol series at −20°C and then drying in the air. The tissue samples were first incubated with the denature biotin labeled Y chromosome specific probe mixed with hybridization solution at 42°C overnight in a moist chamber, and then labeled with streptavidin-FITC (Sigma Chemical Co., Saint Louis, USA) for thirty minutes at 37°C. After washing, the nuclei were counterstained with DAPI (Sigma Chemical Co., Saint Louis, USA). The number of the survival cells was determined by counting the total number of Y chromosome-positive nuclei per microscopic field.
Immunohistochemistry
To demonstrate the differentiated information of the transplanted cells, we performed a double staining. Treated with the blocking solution and incubated at 4°C overnight with mouse cardiac troponin T (cTnT) (Sigma Chemical Co., Saint Louis, USA) monoclonal antibodies, The slides were washed and incubated with goat anti-mouse cy3-conjugated antibody (Sigma Chemical Co., Saint Louis, USA) for thirty minutes at 37°C. The differentiation of SMSCs was assessed by calculating cTnT-positive in relation to the Y chromosome-positive nuclei per microscopic field. At least 32 high-power microscopic fields in infarct and peri-infarct regions were randomly selected and counted in at least three sections from each heart.
Determination of capillary density
Capillary density at the regions of infarct and peri-infarct was determined based on positive vessel for von Willebrand factor (vWF) immuno-staining four weeks after cell transplantation. For quantification of positively stained vessels, five sections of each sample were analyzed. Capillaries were counted in 10 randomly chosen high-power fields each section. Capillary density was expressed as the number of vessels per microscopic field (× 400).
Echocardiography
Transthoracic echocardiography was performed to evaluate changes in the heart function at four weeks after cell transplantation. Each animal was anesthetized and placed in supine position. The heart was imaged in 2D and M-Mode. the recordings were obtained from parasternal long axis view at papillary muscles level using Compact Linear Array probe CL10-5 on an HDI-5000 SONOS CT. Anterior and posterior end-diastolic and end-systolic wall thickness, LV internal dimensions, LV end-systolic (LVESD) and end-diastolic (LVEDD) diameters were measured from at least 3 consecutive cardiac cycles. Indices of LV systolic functions, including LV fractional shortening (LVFS) and LV ejection fraction (LVEF), were calculated using LVFS = ( 
Statistical Analysis
All data were presented as mean ± standard deviation of the mean (S.D.). One-way ANOVA with Scheffe's post hoc test for unequal samples was used to compare numeric data between the three experimental groups. Datasets consisting of two groups only were compared with the use of unpaired Student's t-tests. A level of p < 0.05 was considered statistically significant.
Results
The cytoprotective effects of Diazoxide on SMSCs under H 2 O 2.
In the control group, the cells were fibroblast-like (Fig.  1A) . The cells of H 2 O 2 group were reduced, and some cells became round or irregular-shape (B). In DZ group (C), the morphologic features of the cells were similar to those of the control group. In DZ + 5-HD group (D), the cell viability was better than that of the H 2 O 2 group and worse than that of the DZ group (Fig. 1) .
LDH leakage was significantly reduced in DZpretreated SMSCs, as compared with the SMSCs when exposed to H 2 O 2 (Fig. 2) . The LDH leakage index was lower in the cells of DZ + 5-HD group than H 2 O 2 group and was higher than DZ group (Fig. 2) .
The percentage of the live cells in the DZ group was higher than that in the H 2 O 2 group, while the percentage of the live cells in the DZ + 5-HD group was between the DZ group and H 2 O 2 group (Fig. 3) .
Detection of the integrity of mitochondrial membrane
The integrity of mitochondrial membrane was detected by immunostaining for translocation of cytochrome c from mitochondria to the cytosol. In the cells of control group, cytochrome c in the mitochondria was stained as punctate appearance (Fig. 4) . After treating the cells with H 2 O 2 , cytochrome c in most mitochondria translocated into the cytoplasm, punctate appearance of many cells was disappeared. After pre-treatment with DZ, the effect of H 2 O 2 on translocation of cytochrome c reduced. The cells with punctate appearance in DZ group were more than that in H 2 O 2 group (Fig. 4) .
Expression of phospho-Akt and growth factors
There was no significant difference between the two of H 2 O 2 and control groups in the expression of phospho-Akt protein. Western blot showed markedly upregulated level of phospho-Akt (1.79-fold) in the DZ as compared with H 2 O 2 group (Fig. 5) . Moreover, the expression of HGF mRNA was higher in the DZ group (1.73-fold) than H 2 O 2 group, while the level of HGF mRNA was similar in the H 2 O 2 and control groups. The expression of bFGF mRNA was downregulated in the H 2 O 2 as compared with the control groups. The level of bFGF mRNA was upregulated in the DZ group (2.21-fold), which reached the expression level in the control group. However, there was no significant difference in VEGF expression between the DZ and H 2 O 2 groups, when both of them were significantly higher than control group (Fig. 6) .
Survival of donor cells in vivo and myogenesis
All animals survived the full length of experiments. There were no deaths related with cell transplantation. The animals were sacrificed for studies to assess the survival of SMSCs at four weeks after cells transplantation. The donor cells that survived in the female recipient heart were identified using FISH for Y chromosome (Fig. 7A-F) . The SMSCs injected into the border zones were found in the infarct areas. Immunostaining of the rat heart tissues for cTnT revealed neomyogenesis in the infarct and peri-infarct regions in SMSCs and DZ-pretreated SMSCs groups. Extensive colocalization of the Y chromosome-positive nuclei and cTnT of the cells revealed that SMSCs participated in reparative process by undergoing myogenic differentiation in the infarct and peri-infarct regions. There were significantly higher numbers of Y chromosome positive cells in DZ-pretreated SMSCs than SMSCs group at four weeks after transplantation (Fig. 7G) .
Changes of cardiac morphology
Representative left ventricular sections four weeks after transplantation were shown by Masson staining (Fig.  8A) . Severe collagen fibers were observed and large parts of the myocardium were replaced by scar tissue in control group. The collagen fibers reduction and regenerated myocardia were observed at the infarct regions in SMSCs group.
Significantly slighter fibrosis and more regenerated myocardia were observed at the infarct regions in DZ-pretreated SMSCs than SMSCs group. The quantitative assessment of collagen contents in the DZ-pretreated SMSCs group was 16.3 ± 1.4% as compared with the SMSCs group (18.1 ± 2.1%) and control group (21.1 ± 1.6%) (Fig. 8B) . Ligation consistently resulted in transmural myocardial infarction, exhibiting typical histologic changes including the much thinner free wall of left ventricle and more extensive scar tissue at four weeks after myocardial infarction. The hearts transplanted with SMSCs and DZ-pretreated SMSCs showed smaller infarction size (32.1 ± 4.1%, 28.6 ± 3.2%) than the hearts injected with PBS (41.8 ± 3.3%) (Fig. 8C) .
Capillary density at the infarct and peri-infarct regions of MI was determined based on von Willebrand factor (vWF) immunostaining four weeks after cell transplantation. There was a significant increase in capillary density in SMSCs and DZ-pretreated SMSCs groups when compared with control group. The difference was statistically insignificant between the SMSCs and DZ-pretreated SMSCs groups (Fig.  9) . 
Changes of cardiac function
Four weeks after cell implantation, the cardiac systolic function indices including LV ejection fraction and LV fractional shortening by echocardiography showed significant improvement in DZ-pretreated SMSCs group (62.03 ± 1.9% and 29.01 ± 1.3%) as compared with control group (37.17 ± 1.02%, 15.29 ± 0.46%) and SMSCs group (55.42 ± 1.13, 22.02 ± 0.11%) (Fig. 10) . There was significant difference between the SMSCs and control groups.
Discussion
Apoptosis is a fundamental process in cell survival and cell death. It occurs by activating distinct signaling pathways involving mitochondria, mitochondrial regulatory proteins and caspases (Murry et al. 1986 ). Activation of mitochondrial pathways that promotes cell survival is an endogenously occurring process of "ischemic preconditioning" as a part of the homeostasis (Maulik et al. 1999) . Recent studies indicate that mitochondria have been recognized as regulators of cell death via both apoptosis and necrosis in addition to their essential role for cell survival. Apparently, a brief exposure to ischemia opens the mitochondrial ATP-sensitive potassium (mito-KATP) channels and renders the heart more tolerance to subsequent lethal ischemic injury (Oldenburg et al. 2002; Otani 2008) . Similar cytoprotective effects can be replicated by pharmacological agents that act on the mito-KATP channels (Szewczyk and Wojtczak 2002) . Among these, the channel opener -diazoxide has a complex action on mitochondrial membrane potential, ROS production and mitochondrial permeability transition pore (Dröse et al. 2006; Holmuhamedov et al. 2004; Szewczyk et al. 2006) .
In this study, we shew that diazoxide has significantly attenuated SMSCs apoptosis after oxidative stress injury as assessed by the annexin V/PI staining assay, while DZ reduces LDH release by maintaining cell membrane integrity and viability. The cytoprotection effect of diazoxide on the cells under oxidative stress was partly reversed by 5-HD, supporting the conjecture that 5-HD is a selective mitochondrial K ATP channel blocker. Those results indicated that application of diazoxide as cytoprotective agent may be explained by its non mitochondrial.
In our study, we demonstrated that diazoxide may act quite early in the apoptotic cascade by protecting their mitochondrial membrane integrity and preventing cytochrome c translocation into cytoplasm, thus altering the earlier steps in the apoptotic cascade. We observed there was increase in HGF, bFGF and VEGF expression when cells were exposed to H 2 O 2 , which consistent with previous findings (Niagara et al. 2007) . Although expressions of bFGF and HGF studied in SMSCs pretreated with DZ were upregulated respectively as compared with SMSCs exposed to H 2 O 2 , there was not significant increase in VEGF expression. In light of these results, we inferred a possible role for DZ that it might be able to induce the upregulation of bFGF and HGF, which then activate Akt signaling pathway to improve the survival of cells under oxidative stress. The cytoprotective effects of DZ resulted in elevated expression of phospho-Akt, as activation of Akt and its downstream molecules are known for cytoprotection. Therefore, it is logical to suggest that the upregulated levels of phospho-Akt and its downstream molecules in the DZ-pretreated SMSCs were at least partly responsible for the cytoprotective effects. In summary, we proposed that preconditioning of SMSCs promoted cell survival under oxidative stress by release of paracrine factors such as bFGF and HGF that will bind to their receptor tyrosine kinases to activate the phosphatidylinositol 3-kinase/ Akt pathway.
We observed that survival of the donor SMSCs was higher in DZ-pretreated SMSCs group as compared with SMSCs group at 4 weeks after transplantation based on rat Fig. 9 . Capillary density of the infarct and peri-infarct regions four weeks after cell transplantation. Capillary was determined based on positive vessel for vWF immunostaining. Capillary density was expressed as the number of vessels per microscopic field. *p < 0.001 vs. control (10 animals/group). DZ: diazoxide, SMSCs: selected mesenchymal stem cells. Fig. 10 . The analysis of rat heart function four weeks after therapeutic intervention. There was significant difference in LV function indices in three groups. *p < 0.001 vs. control and # p < 0.01 vs. SMSCs group (10 animals/ group). DZ: diazoxide, SMSCs: selected mesenchymal stem cells.
Y chromosome detection. We hypothesized here that DZpretreated SMSCs provide protection by upregulating the cell survival cytokines that exerted their effects on surrounding cells. In this study, DZ-pretreated SMSCs therapy significantly reduced infarct size and improved cardiac function. These benefits were mainly associated with the reduction of apoptotic cardiomyocytes in peri-infarct areas. Akt and other possible cell survival pathways may be rapidly activated by DZ-pretreated SMSCs in MI model (Gnecchi et al. 2005) . Involvement of protective proteins may conduce overall improvement of cardiac function by preventing cardiomyocytes apoptosis and preservating cardiomyocytes function under ischemia. Fluorescent microscope images after immunostaining for cTnT demonstrated that the engrafted cells underwent myogenic differentiation. Our results agree with the earlier findings that SMSCs have potential to differentiate specially towards cardiomyocytes in the SMSCs transplanted hearts (Zhang et al. 2007 ). The enhanced survival of donor cells undergoing myogenic differentiation and paracrine mechanism led to reduced infarct size and increased LV function. The cumulative effects resulted in attenuation of LV remodeling after MI.
It has been demonstrated that implantation of bone marrow stem cells could induce angiogenesis in ischemic heart (Uemura et al. 2006) . In our present study, higher density of newly formed vessels was observed in the periinfarct region in SMSCs and DZ-pretreated SMSCs groups as compared with the control group, but there was no significant difference between the SMSCs group and DZpretreated SMSCs group. Our data suggest that the viability of transplanted cells is one of the important factors for preservation of myocardial function and the therapeutic angiogenesis is not linearly correlated with the survival rate of the transplanted cells. Our evidence supports the theory that the paracrine effect of SMSCs might be one of the major reasons for therapeutic angiogenesis. Moreover, during the revision of the present manuscript, Afzal et al. (2009) reported that "preconditioning" mesenchymal stem cells with DZ improved the survival rate of the cells in the recipient myocardium.
In conclusion, we are able to show that DZ preconditioning is effective to promote SMSCs survival under oxidative stress in vitro as well as in vivo. In addition, the indices of LV heart function are significantly improved in the hearts transplanted with SMSCs pretreated with DZ. There is great enthusiasm for the potential of stem cell therapies in the treatment of cardiac and chronic degenerative diseases among scientists, physicians, and the patients themselves.
